Know Labs (NYSE:KNW) announced today that it established a scientific advisory board to accelerate development for its glucose monitoring devices.
Seattle-based Know Labs expects the members to advise on algorithm refinement, device development, clinical trial design and research publication strategy. They’ll work alongside the company’s current medical and regulatory advisory board members.
Know Labs develops its proprietary Bio-RFID technology. It uses spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. This technology integrates into wearable, mobile or bench-top form factors. Know Labs developed the first application of Bio-RFID as a non-invasive glucose monitor.
The company said the new advisory board “will be pivotal” in helping the company accelerate development and delivery for Bio-RFID.
“We’re fortunate to be partnering with a team of respected scientific and technical advisors whose areas of expertise are directly related to the work we have underway,” said Ron Erickson, CEO and chair at Know Labs. “Their insights will help us build upon the knowledge and skills of our own team and our strategic partners to further best practices that meet the highest possible standards and to propel us toward clear, unequivocal scientific and public validation of our technology in 2023.”
Here are the new members of Know Labs’ scientific advisory board:
Smarr works as an assistant professor at the Halicioğlu Data Science Institute and the Department of Bioengineering at the University of California, San Diego. His past includes a history of academic and public-private research focused on developing tools for future medicine.
Over the last several years, his research covered continuous physiological data generated from wearables and related technologies. These devices featured uses for women’s health, education outcomes, long-term care and monitoring illnesses of diverse populations.
Zendler serves as a special consultant at Rimkus. She also works as an adjunct research assistant professor in the School of Kinesiology at the University of Michigan.
Know Labs said her work focuses on understanding the role of movement in injury, physical performance, and health. She also focuses on the use of wearable technology to monitor athletes.
Zendler advises sports organizations, national governing bodies and manufacturers. Her areas as an advisor include scientific research, validation and policy development related to human performance and wearables.
Carl Johan Sundberg
A licensed physician, Sundberg serves as professor of exercise physiology at Karolinska Institute in Sweden and Head of the Department of Learning, Informatics, Management and Ethics (LIME). His research centers on human genetics, genomics and epigenetics in relation to exercise. This includes elite athletes, non-athelte populations and patients (cardiovascular, diabetes, psychiatry, oncology).
Sunberg also conducts research in AI/ML-based computerised history taking.
Aloia currently serves as head of sleep and behavioral science at Sleep Number, a maker of beds and accessories. Among his responsibilities are sleep science research, partnerships and collaborations.
He also oversaw clinical sleep research for Philips Respironics for 16 years. Later, Aloia served as Philips Respironics’ global lead for behavior change. He also serves as associate professor in the section of sleep medicine and department of medicine at National Jewish Health.
“Ben, Jessica, CJ and Mark bring expertise, insights and independent perspectives to our medical diagnostic device development at Know Labs,” Erickson added. “We look forward to their contributions. We plan to bring on additional respected medical and technical experts to our advisory boards, as we continue work to deliver our non-invasive diagnostic technology.”
The Scientific advisory board joins the company’s existing medical and regulatory advisory board. That board includes: Dr. James Anderson, Larry Ellingson and Donna Ryan.